Released: ·Last reviewed: ·Methodology v4.1
This page is maintained. Prices are re-read at source and dated; evidence is checked against the published trial. Newest across the site: news · research · corrections.
GLP-1 eligibility checker
An educational self-check of common GLP-1 eligibility factors. Not a diagnosis or guarantee of treatment.
Not medical adviceResults are informational only and are not a diagnosis, a prescription, or a guarantee of treatment eligibility. A licensed clinician determines whether treatment is appropriate.
This is an educational self-check, not a medical assessment. Only a licensed clinician can determine eligibility.
- ☐ BMI ≥ 30, or ≥ 27 with a weight-related condition (general threshold)
- ☐ No personal or family history of medullary thyroid carcinoma or MEN 2
- ☐ Not pregnant or planning pregnancy
- ☐ No history of pancreatitis without clinician clearance
- ☐ Willing to complete a clinical intake and follow-up
Meeting these does not guarantee a prescription; a clinician reviews your full history.
How the dates on this page work. Manufacturer self-pay prices were re-read on 15 October 2026: NovoCare’s Wegovy page and Lilly’s Zepbound savings page. Foundayo prices are carried from LillyDirect pages archived 25 September 2026, because lilly.com blocked automated reads. Figures captured from telehealth provider websites carry the date we read that provider’s page, which may be earlier; where it is, the row or a dated notice says so. We do not restamp a figure we have not re-read.